Ticker ALIM – Alimera – sales, description, marketcap – Tickerday.com

ALIM

Alimera

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 25.16M; Volume: 14.25K; AvgVol 3m: 45.92K; Beta: 2.00;

Cost estimate:

P/E: –; EPS: -1.31; EPS growth quarter/prev quarter: 52.50%;

EPS growth this year: -159.00%; EPS growth past 5 years: -19.30%;

EPS ttm: -1.31;

P/S: 0.44; P/B: ; P/Cashflow: 1.79; P/FCF: ;

Sales: 54.78M; Sales growth quarter/prev quarter: -8.30%; Sales growth past 5 years: 45.00%;

Profitability:

Gross Margin: 86.70%; Profit Margin: -11.70%; Operating Margin: -2.60%;

ROA – return on assets: -13.10%; ROE – return on equity: 17.60%; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.50%; Insider Transactions:-6.16%;

Institutional Ownership: 39.20%; Institutional Transactions: -2.59%;

Data update: 07.10.2020.